title: Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?
abstract: BACKGROUND
  Uremic toxins are emerging as important, non-traditional cardiovascular risk factors in chronic kidney disease (CKD). P-cresol has been defined as a prototype protein-bound uremic toxin. Conjugation of p-cresol creates p-cresylsulfate (PCS) as the main metabolite and p-cresylglucuronide (PCG), at a markedly lower concentration. The objective of the present study was to evaluate serum PCG levels, determine the latter's association with mortality and establish whether the various protein-bound uremic toxins (i.e. PCS, PCG and indoxylsulfate (IS)) differed in their ability to predict mortality.
  
  
  RESULTS
  We studied 139 patients (mean ± SD age: 67±12; males: 60%) at different CKD stages (34.5% at CKD stages 2-3, 33.5% at stage 4-5 and 32% at stage 5D). A recently developed high-performance liquid chromatography method was used to assay PCG concentrations. Total and free PCG levels increased with the severity of CKD. During the study period (mean duration: 779±185 days), 38 patients died. High free and total PCG levels were correlated with overall and cardiovascular mortality independently of well-known predictors of survival, such as age, vascular calcification, anemia, inflammation and (in predialysis patients) the estimated glomerular filtration rate. In the same cohort, free PCS levels and free IS levels were both correlated with mortality. Furthermore, the respective predictive powers of three Cox multivariate models (free PCS+other risk factors, free IS+other risk factors and free PCS+other risk factors) were quite similar--suggesting that an elevated PCG concentration has much the same impact on mortality as other uremic toxins (such as PCS or IS) do.
  
  
  CONCLUSIONS
  Although PCG is the minor metabolite of p-cresol, our study is the first to reveal its association with mortality. Furthermore, the free fraction of PCG appears to have much the same predictive power for mortality as PCS and IS do.
authors.affiliation: INSERM U-1088, Jules Verne University of Picardy, Amiens, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Liabeuf
authors.forename: Griet
authors.initials: G
authors.lastname: Glorieux
authors.forename: Aurelie
authors.initials: A
authors.lastname: Lenglet
authors.forename: Momar
authors.initials: M
authors.lastname: Diouf
authors.forename: Eva
authors.initials: E
authors.lastname: Schepers
authors.forename: Lucie
authors.initials: L
authors.lastname: Desjardins
authors.forename: Gabriel
authors.initials: G
authors.lastname: Choukroun
authors.forename: Raymond
authors.initials: R
authors.lastname: Vanholder
authors.forename: Ziad A
authors.initials: ZA
authors.lastname: Massy
mesh_terms: D000368:Aged; D003408:Cresols / Q000097:blood*; D003710:Demography; D005260:Female; D020719:Glucuronides / Q000097:blood*; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D015999:Multivariate Analysis; D016016:Proportional Hazards Models; D011485:Protein Binding; D051436:Renal Insufficiency, Chronic / Q000097:blood* / Q000150:complications / Q000401:mortality*; D014118:Toxins, Biological / Q000097:blood*; D014511:Uremia / Q000097:blood* / Q000150:complications / Q000401:mortality*
chemical_list: C485699:4-cresylglucuronide; D003408:Cresols; D020719:Glucuronides; D014118:Toxins, Biological